Snowball logo
logo
6006

Harbin Pharmaceutical Group Co Ltd

600664 SHG
¥8.86+¥0.05  (0.57%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
12,80213,808.815,456.616,175.915,964.115,964.8
COGS
9,826.310,446.211,443.211,655.311,815.811,942.5
Gross Profit
2,975.73,362.64,013.44,520.64,148.24,022.3
Operating Expenses & Income
Operating Income
642.4695.8659.6890.2730.5568.7
Total Operating Expenses
2,333.32,666.83,353.73,630.415,233.69,545.2
R&D Expenses
97.73115.8106136.4145141.2
Selling General & Admin Expenses
983.1815833.6833.71,957.82,143.2
Earnings from Continuing Operations
Interest Expense
(112.7)(99.48)(69.44)(68.39)(42.55)(40.03)
Interest Income
15.6528.8747.137.0324.3518.17
Income Tax Expense
220.7188.9176.3184.4-86.39
Net Income
Net Income
371.1465.2395.3628.8361.6309.8
Supplemental
EBIT
447.8557.9618.4849.7--
EBITDA
717821.3878.31,066--
In millions of CNY, except % and values per 1 share